Literature DB >> 11349873

Recommendations for preventing transmission of infections among chronic hemodialysis patients.

.   

Abstract

These recommendations replace previous recommendations for the prevention of bloodborne virus infections in hemodialysis centers and provide additional recommendations for the prevention of bacterial infections in this setting. The recommendations in this report provide guidelines for a comprehensive infection control program that includes a) infection control practices specifically designed for the hemodialysis setting, including routine serologic testing and immunization; b) surveillance; and c) training and education. Implementation of this program in hemodialysis centers will reduce opportunities for patient-to-patient transmission of infectious agents, directly or indirectly via contaminated devices, equipment and supplies, environmental surfaces, or hands of personnel. Based on available knowledge, these recommendations were developed by CDC after consultation with staff members from other federal agencies and specialists in the field who met in Atlanta on October 5-6, 1999. They are summarized in the Recommendations section. This report is intended to serve as a resource for health-care professionals, public health officials, and organizations involved in the care of patients receiving hemodialysis.

Entities:  

Mesh:

Year:  2001        PMID: 11349873

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN: 1057-5987


  105 in total

1.  Remarkable difference in the mode of HCV transmission among haemodialysis patients and IVDAs.

Authors:  S M Alavian; B Hajarizadeh
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

Review 2.  Immune response to hepatitis B vaccine among patients on hemodialysis.

Authors:  Gasim I Gasim; Abdelhaleem Bella; Ishag Adam
Journal:  World J Hepatol       Date:  2015-02-27

Review 3.  Management of patients with hepatitis C infection and renal disease.

Authors:  Chalermrat Bunchorntavakul; Monthira Maneerattanaporn; Disaya Chavalitdhamrong
Journal:  World J Hepatol       Date:  2015-02-27

4.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

Review 5.  Control of antibiotic-resistant bacteria in the office and clinic.

Authors:  Anne G Matlow; Shaun K Morris
Journal:  CMAJ       Date:  2009-05-12       Impact factor: 8.262

Review 6.  Immunizations for renal transplant candidates and recipients.

Authors:  Jennifer Cohn; Emily A Blumberg
Journal:  Nat Clin Pract Nephrol       Date:  2008-11-25

7.  Impact of isolated hepatitis C virus (HCV) core-specific antibody detection and viral RNA amplification among HCV-seronegative dialysis patients at risk for infection.

Authors:  Guillermina Barril; Juan A Quiroga; María Dolores Arenas; Mario Espinosa; Nuria García-Fernández; Secundino Cigarrán; José A Herrero; Gloria del Peso; Pilar Caro; Rebeca García-Agudo; Yésica Amézquita; Ana Blanco; Pilar Martínez-Rubio; José M Alcázar; Emilio González-Parra; Adoración Martín-Gómez; Inmaculada Castillo; Javier Bartolomé; Vicente Carreño
Journal:  J Clin Microbiol       Date:  2014-05-21       Impact factor: 5.948

8.  Outbreak of Clostridium difficile Infections at an Outpatient Hemodialysis Facility-Michigan, 2012-2013.

Authors:  Isaac See; Suparna Bagchi; Stephanie Booth; Daniel Scholz; Andrew I Geller; Lydia Anderson; Heather Moulton-Meissner; Jennie L Finks; Karen Kelley; Carolyn V Gould; Priti R Patel
Journal:  Infect Control Hosp Epidemiol       Date:  2015-04-27       Impact factor: 3.254

9.  HCV response in patients with end stage renal disease treated with combination pegylated interferon alpha-2a and ribavirin.

Authors:  Wyel Hakim; Shehzad Sheikh; Irteza Inayat; Cary Caldwell; Douglas Smith; Marc Lorber; Amy Friedman; Dhanpat Jain; Margaret Bia; Richard Formica; Wajahat Mehal
Journal:  J Clin Gastroenterol       Date:  2009 May-Jun       Impact factor: 3.062

Review 10.  Current hepatitis B virus infection situation in Indonesia and its genetic diversity.

Authors:  Maria Inge Lusida; Yoshihiko Yano
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.